Deirdre Olynick
PhD, MBA
Director | San Francisco, California .png "United States of America")
Healthcare Technology
Drug Discovery, Health Care Industry,...More
Speaking at 1 event
Biography :
Dr. Olynick joined ATOM, a consortium for AI-driven drug discovery, at its founding in October 2017 as Head of Business Development and Operations. At ATOM, Dr. Olynick is responsible for creating high-value public-private partnerships and understanding the AI, data, and experimental landscape that will drive the future of early drug discovery. In the data space, Dr. Olynick has been working with the ATOM team to enable the AI community with sharable curated and newly generated drug discovery data. Dr. Olynick has an MBA from Wharton and a Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign.
************************
**********
For speaker's contact information - Contact us
Specialties
Healthcare Technology
Interested Topics
Drug Discovery, Health Care Industry, Nanotechnology, Semiconductor Fabrication, Powder X-ray Diffraction, Surface Chemistry, Ellipsometry, Atomic Layer Deposition
State Licenses
This section has yet to be updated by the speaker.
Board Certifications
This section has yet to be updated by the speaker.
Professional Association
This section has yet to be updated by the speaker.
Languages
EnglishConference Session Materials
The conference session material has yet to be added by the speaker.
